Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo

NACompletedINTERVENTIONAL
Enrollment

5,053

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2022

Conditions
HIV/AIDSAntiretroviral TherapyPregnancy OutcomesHIV-exposed Infants
Interventions
OTHER

Continuous quality improvement

A quality improvement team at the health district and at the clinics levels. A clinic level QI team will include at least one staff each from antenatal care (ANC), delivery/maternity, and well-child services. The head of the each QI team plus a supervisor from the health district bureau and a study team member constitute the district QI team. Immediately following randomization, we will bring together QI teams to review program and quality indicators from their clinics and across districts to identify key bottlenecks in the care delivery system and agree on an action plan to modify them. QI teams will be responsible for the implementation of the action plan at the level of their respective clinics. Every three months, using data from the monitoring system, the process will be repeated for a duration 18 months. To limit possible contamination, all staff from a randomized district/clinic who may have a dual appointment in another facility will be excluded from QI teams.

Trial Locations (1)

Unknown

Kinshasa School of Public Health, Kinshasa

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

Kinshasa School of Public Health

OTHER

lead

Albert Einstein College of Medicine

OTHER

NCT03048669 - Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo | Biotech Hunter | Biotech Hunter